1 EC 3.1.1.4) hydrolyze 1,2-diacyl-3-sn-phosphoglycerides at the sn-2 position, releasing free fatty acids and lysophospholipids (1, 2) . The growing family of these enzymes, characterized by the molecular mass of 13-18 kDa, the presence of many disulfide bonds in their structure, a requirement of millimolar amounts of Ca 2ϩ for catalytic activity, and a low selectivity for phospholipids with different polar head groups, already comprises nine different groups, IA, IB, IIA, IIB, IIC, III, V, IX, and X (1, (3) (4) (5) . Secretory PLA 2 s were considered primarily as digestive enzymes, but it is now known that they are involved in a number of other important physiological processes such as cell contraction (6) , lipid mediator release (7) , cell proliferation (8) , endotoxic shock (9), acute lung injury (10) , rheumatoid arthritis (11), Crohn's disease (12) , acute pancreatitis (13) , various cancers (14) , and the destruction of pathogenic microorganisms (15) . In addition, many sPLA 2 s found in venom of snakes, insects, lizards, and scorpions (16) display diverse modes of toxicity (reviewed in Ref. 17) . At least some of these (patho)physiological activities of sPLA 2 s are receptor-mediated. The correlation between the binding of mammalian group I sPLA 2 (sPLA 2 -I) to a specific 200-kDa membrane receptor on Swiss 3T3 fibroblasts and DNA synthesis by the cells has been shown (8) . The enhancement of migration of rat embryonic thoracic aorta smooth muscle cells (A7r5) paralleled the binding of sPLA 2 -I to a specific cell receptor (18) . Similarly, the contraction of guinea pig lung parenchyma (19) and prostaglandin synthesis in the mouse osteoblastic MC3T3-E1 cell line were stimulated by the binding of sPLA 2 -I to the cell receptor in a concentration-dependent manner (20) . A receptor for mammalian sPLA 2 -I was purified from bovine corpus luteum (21) . Its sequence identified it as a homologue of the previously characterized M-type receptor for snake venom sPLA 2 s in rabbit skeletal muscle (22) (23) (24) . The M-type receptor has been cloned in different species (23) (24) (25) (26) and found to constitute a new family of Ca 2ϩ -dependent (Ctype) multilectin receptors, which includes the macrophage mannose receptor, the dendritic cell receptor DEC 205 (27) , and the endothelial lectin receptor (see Ref. 28 and reviewed in Ref. 29) . The neurotoxic action of two potent presynaptically acting snake venom sPLA 2 s, ␤-bungarotoxin (␤-Butx) and taipoxin, was found to depend on their specific interaction with proteins, which are, however, completely different from the M-type receptors, namely certain voltage-dependent K ϩ channels (30) and proteins of the pentraxin family (31, 32) . Apparently, one of the reasons for so many different (patho)physiological activities attributed to sPLA 2 lies in the versatility of receptors where they selectively bind and, probably, in their specific tissue distribution (reviewed in Ref. 5 ).
In the study of the molecular basis of neurotoxicity of ammodytoxin C (AtxC), a presynaptically acting group IIA sPLA 2 from the long-nosed viper venom (Vipera ammodytes ammodytes) (33, 34) , we identified a novel high affinity binding protein for sPLA 2 s in porcine cerebral cortex and purified it. The receptor shares some similarity (molecular mass and ligand binding characteristics) with the M-type sPLA 2 receptors, but it is not antigenically related to them. The parallel discovery, reported here, of an M-type sPLA 2 receptor in the liver of the same animal demonstrates for the first time that more than one sPLA 2 receptor of ϳ200 kDa exists in the same species and additionally confirms the exclusivity of the receptor for sPLA 2 in porcine brain.
EXPERIMENTAL PROCEDURES
Materials-Ammodytoxins, ammodytin I 2 and AtnL, were purified from V. ammodytes ammodytes venom as described previously (33, 35 2 ) and bee venom PLA 2 (bvPLA 2 ) were purchased from Roche Molecular Biochemicals. Na 125 I (carrier-free) was from NEN Life Science Products. Disuccinimidyl suberate was from Pierce. Affi-Gel 10 and protein molecular mass standards were obtained from Bio-Rad. Triton X-100 was purchased from Roche Molecular Biochemicals, and concanavalin A-Sepharose, lentil lectin-Sepharose 4B, and wheat germ lectin-Sepharose 6MB were from Amersham Pharmacia Biotech. All other reagents and chemicals were of analytical grade.
Radioiodination of AtxC-Radiolabeled AtxC ( 125 I-AtxC) was prepared as described (36) .
125 I-AtxC was identical to native AtxC in enzymatic, neurotoxic, and immunological characteristics. The specific radioactivity of the preparation was routinely about 300 Ci/mmol.
Membrane Preparation from Porcine Cerebral Cortex-A demyelinated P2 fraction of porcine cerebral cortex was prepared using a slight modification of the method of Bennett et al. (37) . All manipulations were carried out on ice or at 4°C in the presence of the following inhibitors: 2 mM EDTA, 25 g/ml bacitracin, 2 g/ml aprotinin, 1.4 g/ml pepstatin, 1 g/ml leupeptin, 0.2 mM benzamidine, and 0.1 mM phenylmethylsulfonyl fluoride. Protein content in the membrane preparation was determined using the method of Markwell et al. (38) . Bovine serum albumin (BSA) was used as a standard. Membranes were stored at Ϫ70°C.
Preparation of Porcine Liver Membrane Fractions-Porcine liver (60 g) was cut into small pieces and homogenized in 240 ml of 10 mM Hepes, pH 7.4, containing 0.25 M sucrose and 1 mM EDTA. The homogenate was centrifuged at 1,000 ϫ g for 10 min and the pellet (P1 fraction) discarded. The supernatant was further centrifuged at 3,000 ϫ g for 10 min to give the P2 pellet, and the supernatant was spun once again (10,000 ϫ g for 20 min) to give the P3 pellet. The pellets were resuspended in the homogenizing buffer and stored at Ϫ20°C until used.
Solubilization of AtxC-binding Proteins-Membranes from porcine cerebral cortex or liver (2.6 mg of membrane protein/ml) were extracted for 1 h by gentle agitation at 4°C in 75 mM Hepes, pH 8.2, containing 150 mM NaCl, 10 mM SrCl 2 , 0.5 mM EGTA, and 4% (w/v) Triton X-100 and afterward centrifuged at 106,200 ϫ g for 1 h. The detergent extract thus obtained was usually diluted 2-fold with cold deionized water before the next purification step.
Cross-linking of 125 I-AtxC to the Solubilized AtxC-binding ProteinsThe membrane extract or the fractions containing solubilized receptor were incubated for 30 min at room temperature with 125 I-AtxC (10 nM final concentration) in the presence or absence of an unlabeled competitor. Disuccinimidyl suberate, dissolved in 5 l of dimethyl sulfoxide, was added to a final concentration of 100 M. The cross-linking reaction was stopped by the addition of SDS-PAGE sample buffer. Samples were analyzed by SDS-PAGE under reducing conditions (50 mM dithiothreitol) (39) . Gels were dried and autoradiographed at Ϫ70°C using Kodak X-Omat AR films and two intensifying screens.
Chromatography on Wheat Germ Lectin-Sepharose 6MB-9 ml of wheat germ lectin-Sepharose 6MB were equilibrated in 50 mM Hepes, pH 8.2, containing 140 mM NaCl and 2 mM CaCl 2 . The diluted detergent extract was incubated with the gel for 4 h at 4°C under moderate agitation. Two washing steps followed, the first with 80 ml of the equilibration buffer containing 500 mM NaCl and 0.1% (w/v) Triton X-100, and the second with 40 ml of equilibration buffer with 0.3% (w/v) Triton X-100. The bound material was eluted with 10 ml of the equilibration buffer containing 0.1% (w/v) Triton X-100 and 0.6 M N-acetylglucosamine.
Coupling of AtxC to Affi-Gel 10 -6 ml of Affi-Gel 10 were incubated under agitation for 4 h at 4°C with 6 ml of 100 mM MES, pH 6.5, 5 mM CaCl 2 , containing 1 mg/ml AtxC. The amount of toxin bound to the gel was determined by measuring A 280 of the supernatant. Routinely more than 90% of AtxC was bound to the matrix. The resin was washed with 100 ml of 50 mM Hepes, pH 8.2, containing 140 mM NaCl, 2 mM CaCl 2 , and 0.1% (w/v) Triton X-100 and stored in the same buffer at 4°C.
Chromatography on AtxC-Affi-Gel 10 -The gel was equilibrated with 100 ml of 50 mM Hepes, pH 8.2, containing 140 mM NaCl, 2 mM CaCl 2 , and 0.1% (w/v) Triton X-100. The eluate from wheat germ lectin-Sepharose 6MB was incubated with 6 ml of the gel at 4°C for 4 h under gentle agitation. After washing with 100 ml of equilibration buffer, the resin was transferred to the column and washed with the equilibration buffer containing 0.3% (w/v) Triton X-100. The receptors were eluted with 70 mM MES, pH 5.0, containing 100 mM NaCl, 2 mM CaCl 2 , and 0.1% (w/v) Triton X-100. 1-ml fractions were collected and analyzed for the presence of receptor proteins by affinity labeling with 125 I-AtxC as described. The protein composition of each fraction was assessed by SDS-PAGE and silver staining (40) .
Electroblotting and Immuno-chemiluminescence Detection-Samples were run on SDS-PAGE (7.5% acrylamide gels) and transferred for 100 min at 60 V to a nitrocellulose membrane (Serva). The transfer buffer was 25 mM Tris, 200 mM glycine. After transfer, nonspecific binding sites on the membrane were blocked with 1% (w/v) non-fat dried milk in PBS. The membrane was then incubated with guinea pig polyclonal antibodies raised against the rabbit M-type sPLA 2 receptor diluted 1:5,000 in PBS and subsequently with the peroxidase-conjugated goat anti-guinea pig IgG diluted 1:10,000 in PBS (Cappel Research Products). After extensive washing in PBS containing 0.1% (w/v) Tween 20, the secondary antibodies were detected by the BM chemiluminescent Western blotting system (Roche Molecular Biochemicals) following the manufacturer's instructions.
RESULTS

Preparation of Membrane Extracts-In order to solubilize
AtxC-binding proteins from the demyelinated P2 fraction of porcine cerebral cortex, various detergents were tested. Judged on the basis of the lowest AtxC-specific binding site content in the pellet after extraction, the detergent with the highest efficiency was Triton X-100 (data not shown). The ligand binding activity of solubilized receptors was assessed by affinity labeling of the membrane extracts with 125 I-AtxC. Specific adducts shown in Fig. 1A proved that AtxC-binding proteins retain toxin binding activity after solubilization in 4% (w/v) Triton X-100. The addition of proteinase inhibitors to the extraction buffer was not critical because no proteolytic inactivation of the receptors was observed in their absence. In the case of porcine liver the same extraction conditions were successful. Fig. 1A , two specific adducts were observed after cross-linking 125 I-AtxC with the detergent extract of porcine cerebral cortex P2 fraction. Besides the 39-kDa adduct, already identified by affinity labeling experiments on membranes (41), a second specific adduct, slightly smaller than 200 kDa, was observed. Assuming one to one stoichiometry of binding between the receptors and 14-kDa AtxC, there are thus two specific receptors for AtxC in porcine cerebral cortex with apparent molecular masses of 25 (R25) and 180 kDa (R180), respectively.
AtxC-binding Proteins in Detergent Extract of Porcine Cerebral Cortex-As shown in
Characterization of R180 in Solution-The affinity of AtxC for its solubilized receptors was estimated in the cross-linking competition experiment shown in Fig. 1 . The native AtxC displaced 125 I-AtxC from 50% of R180 (IC 50 ) at a concentration of 155 nM, which corresponds to a dissociation constant (K d ) of 145 nM (42) . The K d for the interaction of AtxC with R25 was lower than 25 nM, consistent with the value of 15 nM obtained using the membrane preparation (41) . If Sr 2ϩ and EGTA were replaced with EDTA in the extraction/cross-linking buffer, 125 IAtxC still bound to R180 but not to R25 (data not shown).
Several toxic and non-toxic PLA 2 s as well as some other molecules were examined for their ability to inhibit the 125 IAtxC-R180 adduct formation (Table I) . Binding of 125 I-AtxC to R180 was most potently inhibited by neurotoxic OS 2 (IC 50 ϭ 2 nM) and taipoxin (IC 50 ϭ 5 nM) and also by non-toxic ppPLA 2 (IC 50 ϭ 78 nM). AtxA, a 17-fold more toxic homologue of AtxC, inhibited the specific adduct formation 10-fold better than AtxC, which suggests the importance of R180 in the neurotoxic action of ammodytoxins in porcine cerebral cortex. Inhibition was obtained also with the myotoxic PLA 2 homologue AtnL, which is enzymatically inactive (IC 50 ϭ 39 nM). On the other hand, Agtx, crotoxin, and ␤-Butx, which are potent neurotoxins, and bvPLA 2 were not inhibitory at 10 M concentration. Glycoconjugates of BSA with mannose, N-acetylglucosamine, and galactose also prevented the binding of 125 I-AtxC to R180 although at much higher concentrations (IC 50 values ϭ 570, 335 and 240 nM, respectively), whereas invertase, mannan, and monosaccharides, D-mannose, D-glucose, D-galactose, L-fucose, and N-acetylglucosamine, did not influence the interaction.
R180 was found to be very stable in solution. Its 125 I-AtxC binding ability was unchanged after prolonged storage at Ϫ20°C or repeated freezing and thawing of the sample. Even after overnight incubation at room temperature the activity of R180 was not affected. R180 lost its affinity for AtxC at pH 5.0, but the affinity was completely restored when the pH was again raised to 7.4. R180 was completely retained by concanavalin A, wheat germ lectin, and lentil lectin-Sepharose and subsequently eluted by the respective specific eluants. This indicates that R180 is glycosylated.
Purification of R180 from the Demyelinated P2 Fraction of Porcine Cerebral Cortex-40 ml of the membrane preparation (83 pmol of R180) were extracted with 4% (w/v) Triton X-100. The extract was incubated with wheat germ lectin-Sepharose since we have shown that R180 binds with high affinity and reversibly to this lectin.
125 I-AtxC affinity labeling was used to follow R180 during the isolation. The analysis of the solution after the incubation showed that all the R180 was retained on the resin. Following washing of the gel, elution of R180 was achieved with 0.6 M N-acetylglucosamine. Reduction of Triton X-100 concentration to 0.1% (w/v) in the eluate did not affect the ability of R180 to bind AtxC.
The final purification of R180 was achieved by toxin affinity chromatography. Affi-Gel 10 was chosen as a matrix to which AtxC was attached. The affinity resin with the highest receptor binding activity was synthesized at pH 6.5. Initially, the affinity column was able to bind R25 and R180; however, its capacity for R25 declined very quickly. After using three times, the resin completely lost the R25-retaining ability, whereas its binding of R180 remained unaffected; it became R180-specific. As established by cross-linking experiments, R180 completely lost its toxin binding activity at pH 5.0 and regained it on returning the pH to 7.4. We therefore eluted R180 from the AtxC-Affi-Gel 10 at pH 5.0 and subsequently raised the pH to 7.4, collecting fractions to trace the receptor by 125 I-AtxC affinity labeling. In Fig. 2A , the total protein composition at each purification step is shown using silver-stained SDS-PAGE. A homogenous product with an apparent molecular mass of 180 kDa was obtained after the AtxC-affinity chromatography step (Fig. 2A, lane 7) . Under non-reducing conditions only one band with the same molecular mass was visible (data not shown), showing that R180 is not composed of subunits linked by di- 
I-AtxC binding to R180
The detergent extracts of porcine cerebral cortex P2 membrane fraction (100 g of protein) were incubated with 125 I-AtxC (10 nM final concentration) in the presence of increasing concentrations of the indicated competitors. The cross-linking procedure that followed is described under "Experimental Procedures". IC 50 values were obtained from dose-response curves relating the extent of specific covalent incorporation of 125 I-AtxC to the concentration of unlabeled competitor used in the protection as described in Fig. 1 sulfide bonds. The final product exhibited AtxC binding activity, as shown in Fig. 2B , confirming that the isolated protein is indeed the AtxC receptor. About 2 g of pure R180 was obtained as determined by semiquantitative densitometric analysis of the silver stained SDS-PAGE band. Purification from the membrane fraction was therefore about 14,000-fold and recovery about 13%. The purification yield was essentially the same whether prepared from fresh or frozen brain cortexes.
Immunological Comparison of R180 and Rabbit M-type sPLA 2 Receptor-To characterize R180, Western blot analysis was made using guinea pig polyclonal antibodies raised against the rabbit M-type sPLA 2 receptor. Besides rabbit, these antibodies are able to recognize mouse, rat, and human M-type sPLA 2 receptors. 2 Neither the extract of the demyelinated P2 fraction of porcine cerebral cortex (Fig. 3A, lane 2) nor purified R180 (data not shown) reacted with these antibodies.
An M-type sPLA 2 Receptor Is Present in Pig-We examined porcine liver as a non-neuronal tissue source for potential AtxC receptors.
125 I-AtxC affinity labeled a specific receptor with a slightly higher molecular mass than that of R180 (Fig. 3B) . The liver membrane extract (Fig. 3A, lane 1) cross-reacted with polyclonal anti-rabbit M-type sPLA 2 receptor antibodies, showing that the two sPLA 2 receptors are related. The rabbit M-type sPLA 2 receptor and the porcine liver sPLA 2 receptor were also similar in their low recovery of ligand binding activity following the pH shift from 7.4 to 5.0 and back, and in their instability at room temperature, neither of which was observed in the case of R180. On the contrary, we have found no essential difference in ligand binding specificity between porcine brain (R180) and liver AtxC receptors with the substances tested (Table I) . This is not surprising given that we tested only exogenous molecules (except for ppPLA 2 ), which cannot be physiological ligands for these receptors (43) . DISCUSSION Radiolabeled AtxC was found to interact specifically with the demyelinated P2 membrane fraction of porcine cerebral cortex. The specific binding of 125 I-AtxC was reduced when divalent cations (Ca 2ϩ , Sr 2ϩ , or Ba 2ϩ ) were removed from the solution by EDTA, consistent with the fact that R25 failed to form an adduct with 125 I-AtxC in the presence of chelator (41) . By studying the detergent extract of the membranes, we showed that the remaining EDTA-independent specific binding of AtxC is associated with a 180-kDa membrane protein. The equivalent experiments using intact membranes failed to show the presence of this component, although re-examination of the 125 I-AtxC cross-linking patterns, especially those that were overexposed, confirmed the formation of the specific adduct at 200 kDa on the membrane preparations also. The reason for the large difference in intensity of the specific signal near 200 kDa between the membranes and the membrane extract most probably indicates that the topology of R180 in the membrane is unsuitable for efficient cross-linking.
R180 and R25 differ considerably in their ligand binding specificities. Whereas R25 binds exclusively neurotoxic ammodytoxins (41), R180 binds both toxic and non-toxic sPLA 2 s with high affinity (Table I) . R180 recognizes sPLA 2 s of both mammalian group I (ppPLA 2 ) and non-mammalian group I (OS 2 and taipoxin), as well as group II sPLA 2 s (ammodytoxins 2 G. Lambeau, personal communication. and AtnL). The specific binding of the enzymatically inactive sPLA 2 homologue AtnL to R180 confirmed that the ability of sPLA 2 to bind to R180 is independent of the enzymatic activity.
A two-step procedure has been developed to isolate R180. The wheat germ lectin-Sepharose chromatography step was important to decrease the concentration of Triton X-100 from 2% (w/v) in the extract to 0.1% (w/v) in the eluate without diluting the sample. The decreased concentration of the detergent and increased concentration of R180 in the eluate were crucial for the success of the final purification step, AtxC affinity chromatography. Freshly synthesized AtxC-Affi-Gel 10 resin retained both AtxC-binding proteins, R25 and R180, but after the third application, the resin became only R180-specific. From the competition studies it is clear that AtxC has different receptor interaction sites for R25 and R180 (41) . A possible explanation for the observed binding ability of AtxC-Affi-Gel 10 column could be in a minor conformational change of immobilized AtxC, which would lead to a loss of affinity for one receptor but not for the other. The AtxC affinity step gave rise to highly purified R180 as judged by SDS-PAGE analysis.
As a high affinity binding receptor for snake venom PLA 2 s, R180 resembles the M-type sPLA 2 receptor, which has been purified from rabbit skeletal muscle (22) . Their ligand binding specificities are very similar. Both avidly bind OS 2 , taipoxin, and ppPLA 2 but not bvPLA 2 , crotoxin, and ␤-Butx. Invertase, mannan, D-mannose, D-glucose, D-galactose, L-fucose, and Nacetylglucosamine, which are the ligands of macrophage mannose receptor (44), do not affect 125 I-AtxC binding to R180, just as they also failed to influence the interaction of 125 I-OS 2 with the rabbit M-type sPLA 2 receptor (22) . R180 also displays lectin-like properties, indicating the presence of carbohydrate recognition domains in its structure. Its much lower affinity for BSA glycoconjugates compared with the rabbit M-type sPLA 2 and macrophage mannose receptors (24, 44) suggests, however, that the lectin properties of R180 are not physiologically relevant. The molecular masses of R180 and rabbit M-type sPLA 2 receptor are practically identical, and both proteins are glycosylated. Nevertheless, the two receptors differ substantially in their abundance in brain. Although we detected 400 fmol of R180 per mg of membrane protein in porcine brain membrane preparation, only 12 fmol of M-type sPLA 2 receptor per mg of protein was found in rabbit brain using 125 I-OS 1 , an M-type receptor-specific ligand (45) . The mouse, rat, and human Mtype sPLA 2 receptor homologues were not detected at all in brain by RNA blotting analysis using cDNA probes derived from respective animals and 125 I-OS 1 binding studies (25, 26, 45) .
The relation between R180 and the M-type sPLA 2 receptor from rabbit skeletal muscle was further investigated by Western blotting with guinea pig polyclonal antibodies against the latter. The antibodies, which cross-react also with mouse, rat, and human M-type sPLA 2 receptors, 2 failed to recognize R180, but they cross-reacted with the AtxC receptor discovered in porcine liver. In pig, therefore, two immunologically different sPLA 2 receptors of ϳ200 kDa are present. One of them, found in liver, is a homologue of the M-type sPLA 2 receptors, whereas the other, purified from brain, is quite different. Based on primary structure comparison between sPLA 2 binding regions in the M-type sPLA 2 receptors from different animals, and on the analysis of the human genome for the M-type sPLA 2 receptor genes, it was concluded that M-type sPLA 2 receptors from different animals are probably encoded by homologous, single copy genes (25) . This finding further emphasizes the distinction between R180 and M-type sPLA 2 receptors.
Cupillard et al. (43) showed that M-type sPLA 2 receptors differ substantially in affinity for the respective endogenous group I and II sPLA 2 s and suggested the existence of other types of sPLA 2 receptors distinct from the M-type. According to the molecular mass and some ligand binding characteristics, the porcine brain sPLA 2 receptor probably belongs to the multilectin mannose receptor family (29) . However, it cannot be a member of the same group of receptors as the M-type sPLA 2 receptors, which are all immunologically related, and it evidently represents (one of) the "missing" new type sPLA 2 receptor(s).
The physiological role of the new sPLA 2 receptor and its involvement in the neurotoxic action of AtxC remain important questions. In view of the relatively high abundance of R180 in the brain, its function should be very specific, although its natural ligands still have to be identified. Recently, besides endogenous group I and II sPLA 2 s, group IIC, V, and X sPLA 2 s have been described which may also be potential candidates, but their receptor binding properties have not yet been determined.
